33450 Federal Register / Vol. 74, No. 132 / Monday, July 13, 2009 / Notices 

Dated: June 16, 2009. 

Charlene Frizzera, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E9–16677 Filed 7–10–09; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Advisory Committee for Women’s 

Services; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given of a Web-based 

meeting of the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) Advisory Committee for 

Women’s Services on July 29, 2009 from 

2 p.m. to 4:30 p.m. The meeting is open 

to the public and will include an update 

on current and emerging research on 

women-specific substance use and 

mental health issues. 

ACWS members and invited 

presenters will participate in this 

meeting through remote internet 

connection. On-site attendance by the 

public will be limited to space available. 

The meeting can also be accessed by the 

public via teleconference. To obtain 

teleconference call-in numbers and 

access codes, to make arrangements to 

attend on-site, or to request special 

accommodations for persons with 

disabilities, please communicate with 

Ms. Nevine Gahed, Designated Federal 

Official (see contact information below). 

Substantive meeting information and 

a roster of Committee members may be 

obtained either by accessing the 

SAMHSA Committees’ Web site at 

https://nac.samhsa.gov/ 

WomenServices/index.aspx, or by 

contacting Ms. Gahed. The transcript for 

the meeting will also be available on the 

SAMHSA Committees’ Web site within 

three weeks after the meeting. 

Committee Name: SAMHSA Advisory 

Committee for Women’s Services. 

Date/Time/Type: Wednesday, July 29, 

2009, from 2 p.m. to 4:30 p.m.: Open. 

Place: 1 Choke Cherry Road, Sugarloaf 

Conference Room, Rockville, Maryland 

20857. 

Contact: Nevine Gahed, Designated 

Federal Official, SAMHSA Advisory 

Committee for Women’s Services, 1 

Choke Cherry Road, Room 8–1112, 

Rockville, Maryland 20857, Telephone: 

(240) 276–2331; FAX: (240) 276–2220 

and E-mail: 

nevine.gahed@samhsa.hhs.gov. 

Dated: July 6, 2009. 

Toian Vaughn, 

Committee Management Officer, Substance 

Abuse and Mental Health Services 

Administration. 

[FR Doc. E9–16457 Filed 7–10–09; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Capacity 

Building Assistance (CBA) To Improve 

the Delivery and Effectiveness of 

Human Immunodeficiency Virus (HIV) 

Prevention Services for High-Risk and/ 

or Racial/Ethnicity Minority 

Populations, Program Announcement 

Number PS09–906, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 8:30 a.m.–5:30 p.m., July 

28, 2009 (Closed). 

Place: CDC, Corporate Square Campus, 8 

Corporate Boulevard, Atlanta, Georgia 30329. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include an initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Capacity Building Assistance 

(CBA) to Improve the Delivery and 

Effectiveness of Human Immunodeficiency 

Virus (HIV) Prevention Services for HighRisk and/or Racial/Ethnicity Minority 

Populations, PS09–906.’’ The meeting was 

initially held June 15–18, 2009. A reviewer 

conflict of interest was confirmed after the 

meeting commenced and a reviewer for 

another application was unable to participate 

due to sudden illness; therefore, the panel 

will be reconvened to review the affected 

applications. 

Contact Person for More Information: 

Monica Farmer, M.Ed., Public Health 

Analyst, Strategic Science and Program Unit, 

Office of the Director, Coordinating Center 

for Infectious Diseases, CDC, 1600 Clifton 

Road, NE., Mailstop E–60, Atlanta, GA 

30333, Telephone: (404) 498–2277. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: July 7, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–16460 Filed 7–10–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Strengthening 

National Capacity in Malaria and Other 

Infectious Disease Operations 

Research, Funding Opportunity 

Announcement (FOA) CK09–004, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 2:30 p.m.–4:30 p.m., 

July 28, 2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

‘‘Strengthening National Capacity in 

Malaria and Other Infectious Disease 

Operations Research, Funding 

Opportunity Announcement (FOA) 

CK09–004.’’ This meeting was initially 

held June 1, 2009. A reviewer was 

unable to participate unexpectedly and 

the meeting was held in the absence of 

the required quorum; therefore, the 

panel will be reconvened to review the 

application received in response to the 

announcement. 

FOR FURTHER INFORMATION CONTACT: 

Wendy Carr, PhD, CDC, 1600 Clifton 

Road, NE., Mailstop D60, Atlanta, GA 

30333, Telephone: (404) 498–2276. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

mstockstill on DSKH9S0YB1PROD with NOTICES